Related Experiment Video
Updated: Oct 7, 2026

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Involvement of the leader sequence in Sendai virus pathogenesis revealed by recovery of a pathogenic field isolate
Yutaka Fujii1, Takemasa Sakaguchi, Katsuhiro Kiyotani
1Department of Virology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
Abstract:
We previously demonstrated that a systematic passage of a pathogenic field isolate of Sendai virus (SeV), the Hamamatsu strain, in embryonated eggs caused attenuation of virulence to mice, and we isolated viral clones of distinct virulence (K. Kiyotani et al. Arch. Virol. 146:893-908, 2001). One of the clones, E15cl2, which was obtained from the virus at the 15th egg passage of E0, the parental Hamamatsu clone for egg passage, had 165-fold-attenuated virulence to mice and possessed only four mutations in the entire 15,384-base genome: in an antigenomic sense, U to A at position 20 (U20A) and U to A at position 24 (U24A) in the leader sequence, the promoter for transcription and replication, and A to G at position 9346 (silent) and A to U at position 12174 (Ser to Cys) in the L gene. To examine the possibility that leader mutations affect virus pathogenesis, we recovered live viruses from cDNA derived from the Hamamatsu strain. A mutant virus possessing either a mutation of U20A or U24A in the leader sequence showed a slightly lower pathogenicity than that of the parental virus, whereas a double mutant virus possessing both of the mutations showed 25-fold-attenuated virulence, accompanying a significantly lower virus replication in the mouse lung. Replications of the leader mutant viruses were also impaired in a primary culture of mouse pulmonary epithelial cells but not in chicken embryo fibroblasts. These findings suggest that leader mutations of SeV affect virus pathogenesis by altering virus replication in a host-dependent manner.
Insights
Sendai virus (SeV) leader mutations reduce mouse virulence by impairing virus replication in lung cells. These findings highlight host-dependent effects of viral genetic changes on pathogenesis.
Area of Science:
- Virology
- Molecular Biology
- Pathogenesis
Background:
- Sendai virus (SeV) passage in embryonated eggs attenuates virulence.
- Specific viral clones exhibit distinct virulence levels.
- Previous work identified four mutations in an attenuated SeV clone (E15cl2).
Purpose of the Study:
- To investigate the role of leader sequence mutations in SeV pathogenesis.
- To determine if leader mutations affect virus replication and virulence in mice.
Main Methods:
- Recovery of live SeV mutants from cDNA.
- Assessment of viral pathogenicity and replication in mice.
- In vitro replication assays in mouse pulmonary epithelial cells and chicken embryo fibroblasts.
Main Results:
- Single leader mutations (U20A or U24A) slightly reduced SeV pathogenicity.
- A double leader mutant (U20A/U24A) showed 25-fold attenuated virulence and significantly lower replication in mouse lungs.
- Leader mutant replication was impaired in mouse pulmonary cells but not chicken embryo fibroblasts.
Conclusions:
- SeV leader mutations contribute to altered virus pathogenesis.
- Mutations in the leader sequence affect virus replication in a host-dependent manner.
- These findings provide insights into the molecular mechanisms of SeV attenuation.
Related Concept Videos
Retrovirus Life Cycles
Leaky Scanning

